This legislative proposal aims to amend the Controlled Substances Act to address concerns surrounding tianeptine. It seeks to formally classify tianeptine , including its analogues, salts, and isomers, as a Schedule III controlled substance . This classification would subject tianeptine to stricter regulations regarding its manufacture, distribution, and possession, similar to other substances in Schedule III. The bill specifies that these changes to the Controlled Substances Act will become effective 90 days after the date of its enactment , enhancing public safety by controlling this substance.